Frazier Life Sciences Management, L.P. Verona Pharma PLC Transaction History
Frazier Life Sciences Management, L.P.
- $1.59 Billion
- Q1 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Verona Pharma PLC stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,457,850 shares of VRNA stock, worth $256 Million. This represents 13.82% of its overall portfolio holdings.
Number of Shares
3,457,850
Previous 3,383,950
2.18%
Holding current value
$256 Million
Previous $157 Million
39.7%
% of portfolio
13.82%
Previous 9.42%
Shares
7 transactions
Others Institutions Holding VRNA
# of Institutions
291Shares Held
74.3MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$485 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$408 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$290 Million17.31% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$214 Million3.9% of portfolio
-
Rtw Investments, LP New York, NY2.85MShares$211 Million2.96% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.51B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...